KURA today
$7.73+$0.16 (+2.11%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourLeaning Bearish
15 minBearish
5 minStrong Bearish
Daily trend turns up above $10.96
Key levels
Resistance$9.28
Resistance$8.39
Support$7.54
Support$6.75
Latest news & SEC filings
EarningsKura Oncology Posts Q3 2026 Financials
SEC FilingKura Oncology, Inc. filed an automatic shelf registration for future offerings (Form S-3ASR)
DealKura Oncology submits shelf registration for future securities sale
EarningsKura Oncology reports $492.1M in cash and short-term investments for Q3
All KURA news →About Kura Oncology
Kura Oncology is a biopharmaceutical company that develops precision medicines for cancer. Its approved drug, KOMZIFTI (ziftomenib), is an oral menin inhibitor for adults whose acute myeloid leukemia has returned or not responded and carries an NPM1 mutation. The company also develops darlifarnib, a farnesyl transferase inhibitor, and other small molecule candidates for solid tumors and blood cancers. It sells KOMZIFTI in the United States, where it also handles manufacturing, and works with partners including Kyowa Kirin.
Based on the company's 10-K filed Mar 5, 2026.
Nasdaq · Healthcare
Kura Oncology, Inc. (KURA)
What Is the Price Target for KURA?
SEPT Low Target
$23.00
SEPT Mid Target
$27.00
SEPT High Target
$38.00
Analyst Consensus
$27.00
Is KURA a Buy or Sell Right Now?
Thesis
- •Revenue growing 25.2% YoY with UNKNOWN trend — consistent growth.
- •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment rising.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for KURA.
Start Free Trial →Is KURA Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$20.60
0
Moat Score
NONE
2/9
Piotroski Score
-1.8
Altman Z-Score
What Is Smart Money Doing with KURA?
Insider Signal
SELLING
0 buys / 17 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| FORD KATHLEEN | officer | Sale | 3,668 | $39K | Sep 29, 2026 |
| Leoni Mollie | officer | Sale | 28,802 | $310K | Sep 29, 2026 |
| Powl Brian T. | officer | Sale | 15,430 | $166K | Sep 29, 2026 |
| Bair Teresa Brophy | officer | Sale | 8,442 | $89K | Sep 28, 2026 |
| FORD KATHLEEN | officer | Sale | 6,906 | $72K | Sep 28, 2026 |
| Leoni Mollie | officer | Sale | 12,448 | $131K | Sep 28, 2026 |
| DOYLE THOMAS JAMES | officer | Sale | 4,607 | $48K | Sep 28, 2026 |
| Powl Brian T. | officer | Sale | 9,020 | $95K | Sep 28, 2026 |
| Powl Brian T. | officer | Sale | 8,000 | $84K | Sep 28, 2026 |
| Burrows Francis | officer | Buy | 30,000 | $185K | Sep 24, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →KURA Growth Story
Revenue YoY
25.2%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-57.43%
FCF Growth YoY
-152.8%
Revenue Trend
UNKNOWN
Dark Pool Trades for KURA
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for KURA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 12:05:55 | $7.75 | 1,200 | $$9K | SELL |
| 21:26:37 | $7.73 | 1,185 | $$9K | BUY |
| 21:00:10 | $7.73 | 3,700 | $$29K | SELL |
| 21:00:10 | $7.73 | 12,277 | $$95K | SELL |
| 21:00:03 | $7.73 | 1,100 | $$9K | SELL |
5 dark pool trades shown · $$150K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for KURA
PREVIEWSEPT Investing provides real-time options flow tracking for KURA, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $8 | Dec 18 | 37 | $$450 | 5 | SWEEP |
| CALL | $8 | Nov 20 | 9 | $$165 | 3 | SWEEP |
| CALL | $8 | Nov 20 | 9 | $$55 | 1 | SWEEP |
| CALL | $8 | Nov 20 | 9 | $$165 | 3 | SWEEP |
| CALL | $8 | Nov 20 | 9 | $$165 | 3 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Kura Oncology, Inc. (KURA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →KURA — frequently asked questions
What is KURA stock price today?
Kura Oncology, Inc. (KURA) is at $7.73, up 2.11% (+$0.16) at the Nov 11, 2026 close.
Why is KURA stock moving today?
Latest KURA news — Nov 10, 2026: Kura Oncology Posts Q3 2026 Financials · Nov 10, 2026: Kura Oncology, Inc. filed an automatic shelf registration for future offerings (Form S-3ASR)
What is the KURA price target?
The average analyst price target for KURA is $27.00, ranging from $23 to $38, based on 4 analysts. Latest: JP Morgan initiates on Oct 1, 2026.
What do analysts rate KURA?
Analyst ratings for KURA: 0 Buy, 6 Hold, 0 Sell — consensus Hold.
Did KURA beat earnings?
KURA last reported on Aug 12, 2026: EPS -$0.77 vs -$0.88 expected — a beat of 12.2%.
Does KURA pay a dividend?
KURA does not currently pay a dividend.
What are KURA support and resistance levels?
Support: $7.54, $6.75, $5.45. Resistance: $8.39, $9.28, $9.99.
What are insiders doing with KURA?
Insider activity: SELLING, 0 buys and 17 sells in the last 90 days.
What is the latest news on KURA?
Nov 10, 2026: Kura Oncology Posts Q3 2026 Financials · Nov 10, 2026: Kura Oncology, Inc. filed an automatic shelf registration for future offerings (Form S-3ASR) · Nov 10, 2026: Kura Oncology submits shelf registration for future securities sale